New drug combo aims to tame rare histiocytosis in adults
NCT ID NCT07187193
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 2 trial is testing a combination of low-dose cytarabine (a chemotherapy drug) and thalidomide in 50 adults with untreated Langerhans cell histiocytosis (LCH), a rare disease where immune cells build up and damage tissues. Participants receive up to 24 cycles of treatment over about two years. The goal is to see if this combo can control the disease and improve survival, with fewer side effects than standard treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cytarabine and thalidomide
- What this could lead to
- If successful, this combination could offer a new treatment option for adults with Langerhans cell histiocytosis, potentially controlling the disease and improving survival.
- What could go wrong
- This is a small, early-phase trial with no control group, so results may not be definitive. Side effects from chemotherapy and thalidomide are possible, and the treatment may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LANGERHANS CELL HISTIOCYTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted pill tame a rare immune disease?
- Massive study tracks hidden toll of rare immune diseases
- Rare disease study probes hidden brain effects
- New hope for kids with rare cell disease: targeted pill tested
- New hope for kids with rare immune disorder: international trial tests drug cocktails
- Robot buddies let kids with cancer attend class from hospital bed